IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 223 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,602,343 | -37.6% | 352,167 | -3.4% | 0.00% | -33.3% |
| Q2 2023 | $2,567,086 | +175008.2% | 364,643 | +52.0% | 0.00% | +50.0% |
| Q1 2023 | $1,466 | -2.3% | 239,891 | +2.2% | 0.00% | 0.0% |
| Q4 2022 | $1,500 | -99.9% | 234,677 | -1.0% | 0.00% | -33.3% |
| Q3 2022 | $2,272,000 | -6.8% | 237,129 | +7.3% | 0.00% | -25.0% |
| Q2 2022 | $2,439,000 | +18.9% | 220,944 | +79.3% | 0.00% | +33.3% |
| Q1 2022 | $2,052,000 | -20.1% | 123,237 | -8.4% | 0.00% | 0.0% |
| Q4 2021 | $2,568,000 | -19.9% | 134,519 | +3.5% | 0.00% | -25.0% |
| Q3 2021 | $3,204,000 | -12.0% | 129,916 | -7.1% | 0.00% | -20.0% |
| Q2 2021 | $3,639,000 | -16.2% | 139,853 | +2.0% | 0.01% | -16.7% |
| Q1 2021 | $4,342,000 | -35.5% | 137,150 | -5.5% | 0.01% | -33.3% |
| Q4 2020 | $6,737,000 | +39.7% | 145,189 | -0.9% | 0.01% | +12.5% |
| Q3 2020 | $4,821,000 | +13.6% | 146,438 | -5.3% | 0.01% | +14.3% |
| Q2 2020 | $4,244,000 | -14.3% | 154,609 | -6.5% | 0.01% | -30.0% |
| Q1 2020 | $4,951,000 | +10.9% | 165,382 | +2.5% | 0.01% | +42.9% |
| Q4 2019 | $4,465,000 | +58.5% | 161,301 | +4.2% | 0.01% | +40.0% |
| Q3 2019 | $2,817,000 | -26.0% | 154,803 | -0.3% | 0.01% | -28.6% |
| Q2 2019 | $3,806,000 | +196.0% | 155,208 | +14.8% | 0.01% | +250.0% |
| Q1 2019 | $1,286,000 | +6.8% | 135,230 | -0.6% | 0.00% | -33.3% |
| Q4 2018 | $1,204,000 | +50.3% | 136,088 | +91.1% | 0.00% | +50.0% |
| Q3 2018 | $801,000 | -18.1% | 71,209 | -6.8% | 0.00% | 0.0% |
| Q2 2018 | $978,000 | -18.4% | 76,424 | +7.7% | 0.00% | -33.3% |
| Q1 2018 | $1,199,000 | +168.8% | 70,959 | +27.4% | 0.00% | +200.0% |
| Q4 2017 | $446,000 | -10.3% | 55,718 | -13.0% | 0.00% | 0.0% |
| Q3 2017 | $497,000 | +6.2% | 64,065 | +0.6% | 0.00% | 0.0% |
| Q2 2017 | $468,000 | – | 63,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |